AI-generated summary
The authors report a case study of one 55-year-old man with a giant serous pigment epithelium detachment from chronic central serous chorioretinopathy in the left eye. After photobiomodulation sessions, the detachment and subretinal fluid resolved over 12 months and visual acuity improved from 20/80 to 20/25. The authors conclude the treatment can be considered safe and effective, but this is a single case without a control group.
- Participants
- 1
- Who or what was studied
- One 55-year-old man with chronic central serous chorioretinopathy and a giant macular serous pigment epithelium detachment in the left eye
- Limits stated in the abstract
- This is a single case report with no control group, so the conclusion that the treatment is safe and effective cannot be generalized.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Case report. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.